androstenedione has been researched along with Weight Reduction in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azadi-Yazdi, M; Fallahzadeh, H; Karimi-Zarchi, M; Nadjarzadeh, A; Salehi-Abargouei, A | 1 |
Alipour, F; Karimi Jashni, H; Miri, M | 1 |
Cavazza, C; Ciampaglia, W; Cognigni, GE; Gambineri, A; Ibarra Gasparini, D; Pagotto, U; Pasquali, R | 1 |
Fleming, R; Harborne, LR; Norman, JE; Sattar, N | 1 |
Farmakiotis, D; Katsikis, I; Kourtis, A; Krassas, G; Panidis, D; Rousso, D | 1 |
Deurenberg, P; Koppeschaar, HP; Leenen, R; Seidell, JC; van der Kooy, K | 1 |
3 trial(s) available for androstenedione and Weight Reduction
Article | Year |
---|---|
Effects of Dietary Approach to Stop Hypertension diet on androgens, antioxidant status and body composition in overweight and obese women with polycystic ovary syndrome: a randomised controlled trial.
Topics: Adult; Androgens; Androstenedione; Antioxidants; Biomarkers; Blood Glucose; Body Composition; Body Mass Index; Dietary Approaches To Stop Hypertension; Female; Humans; Insulin; Insulin Resistance; Obesity; Overweight; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Weight Loss; Young Adult | 2017 |
Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses.
Topics: Administration, Oral; Androstenedione; Blood Glucose; Dehydroepiandrosterone Sulfate; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Luteinizing Hormone; Metformin; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Weight Loss | 2005 |
Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Topics: 17-alpha-Hydroxyprogesterone; Androgens; Androstenedione; Anti-Obesity Agents; Blood Glucose; Body Mass Index; Caloric Restriction; Case-Control Studies; Combined Modality Therapy; Dehydroepiandrosterone Sulfate; Female; Follicle Stimulating Hormone; Humans; Insulin; Insulin Resistance; Lactones; Luteinizing Hormone; Obesity; Orlistat; Polycystic Ovary Syndrome; Prolactin; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Time Factors; Treatment Outcome; Weight Loss | 2008 |
3 other study(ies) available for androstenedione and Weight Reduction
Article | Year |
---|---|
Effect of exercise intensity on weight changes and sexual hormones (androstenedione and free testosterone) in female rats with estradiol valerate-induced PCOS.
Topics: Androstenedione; Animals; Estradiol; Exercise Therapy; Female; Polycystic Ovary Syndrome; Rats, Wistar; Running; Testosterone; Weight Loss | 2014 |
Heterogeneity in the responsiveness to long-term lifestyle intervention and predictability in obese women with polycystic ovary syndrome.
Topics: Adult; Aged; Androstenedione; Female; Follow-Up Studies; Humans; Insulin Resistance; Intra-Abdominal Fat; Logistic Models; Middle Aged; Obesity; Polycystic Ovary Syndrome; Predictive Value of Tests; Risk Reduction Behavior; Weight Loss | 2011 |
Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy.
Topics: Adipose Tissue; Adult; Androstenedione; Body Composition; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Diet, Reducing; Estradiol; Estrone; Female; Humans; Insulin; Male; Middle Aged; Obesity; Premenopause; Sex Characteristics; Sex Hormone-Binding Globulin; Testosterone; Weight Loss | 1994 |